NovoPen ® 1.5 and NovoPen ® 3) in the diabetes/insulin therapy area that contained evidence of the effects of NovoPen ® in a variety of categories. Of the studies identified, most showed that ...
At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback